Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

PMP22 Gene Roussy–Lévy Syndrome Genetic Test

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed genetic expert.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Core Metrics

  • Price: 2,800 AED
  • Turnaround Time: 3 – 4 Weeks
  • Sample Type: Whole Blood (3 mL)
  • Methodology: Next-Generation Sequencing (NGS)

Test Overview & Methodology

This Next‑Generation Sequencing (NGS) test analyzes the entire coding region and splice sites of the PMP22 gene to identify pathogenic variants responsible for Roussy–Lévy syndrome (a hereditary motor and sensory neuropathy resembling Charcot‑Marie‑Tooth disease). The test achieves >99% coverage of the coding region and detects point mutations, small indels, and copy number variants.

Feature Our PMP22 NGS Test Conventional Single‑Gene Test
Method Full‑gene NGS with bioinformatic coverage >99% Sanger sequencing of selected exons or MLPA for deletions/duplications
Detection Scope Point mutations, small indels, and copy number variants Only previously known hotspot mutations or common CNVs
Turnaround Time 3 – 4 Weeks 4 – 8 Weeks (depending on sequential testing)
Cost 2,800 AED ~3,500 AED (if multiple tests required)
UAE Compliance Full DHA/MOHAP nomenclature & data privacy Varying

Physician Insight & Safety Protocols

Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) advises: “I understand the deep concern a patient and family feel when a hereditary neuropathy is suspected. This advanced genetic test provides essential molecular confirmation, but the result must always be interpreted alongside a detailed neurological exam, family history, and genetic counselling. A positive or negative finding does not replace clinical judgement.”

Advisory Notice

Do not discontinue any prescribed medication or modify your treatment plan based solely on a genetic test result without consulting your treating physician.

Exclusion Criteria & Emergency Red Flags

  • Exclusion: This test is not recommended for asymptomatic children under 18 years without legal guardian consent and a formal genetic counselling session.
  • Exclusion: Patients with an acute intercurrent illness or those unable to provide a standard blood sample may require rescheduling.
  • Emergency Red Flags: If you experience sudden worsening of weakness, difficulty breathing, choking, or loss of consciousness, seek emergency care immediately – do not wait for genetic test results.

Patient FAQ & Clinical Guidance

1. What is Roussy–Lévy syndrome and why is the PMP22 gene tested?

This test detects pathogenic variants in the PMP22 gene causing Roussy–Lévy syndrome, a hereditary neuropathy with gait ataxia and distal muscle wasting. The PMP22 gene is associated with peripheral nerve myelin formation; mutations lead to characteristic neuropathy.

2. How is the sample collected and what is the turnaround time?

A certified phlebotomist collects 3 mL of whole blood via VIP mobile phlebotomy home service (available daily 8 AM to 11 PM). Results are ready in 3–4 weeks, followed by a genetic counselling tele-appointment.

3. Will insurance cover the cost of this genetic test in the UAE?

Many UAE insurers reimburse genetic testing when medically necessary. Send your Emirates ID and policy details via WhatsApp to +971 54 548 8731 for a direct billing eligibility check.

UAE Regulatory & Data Privacy Adherence

Compliance Statement

ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139). All processes comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name PMP22 Gene Roussy–Lévy Syndrome Genetic Test
Price (AED) 2,800
Turnaround Time 3 – 4 Weeks
Sample Type / Matrix Whole Blood (3 mL)
Methodology Used Next-Generation Sequencing (NGS)
ICD-10-CM Code G60.0
LOINC Code 48018-6
DHA Facility License & Laboratory Address License No: 1143
Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians